Four Analyst Calls on Monday Worth Noting: Alere Inc (ALR), SolarCity Corp (SCTY)

Page 1 of 2

Sometimes an analyst issues a revised outlook or changes his/her rating, but does not inform investors of the reasons behind the call. These typically move stocks on the call alone; the price target and outlook. However, some analysts provide detailed reasons behind the call; these are the outlooks that should be noted and used as part of your fundamental research. Therefore, I am taking a look at such outlooks and determining the best way to utilize the information.

Company Ticker Firm Call
Angie’s List Inc (NASDAQ:ANGI) Oppenheimer Reaffirmed Outperform
SolarCity Corp (NASDAQ:SCTY) GTM Research Note
Alere Inc
(NYSE:ALR) Wedbush Neutral
Amgen, Inc. (NASDAQ:AMGN) William Blair Market Perform

Upgrades

Shares of online social media company Angie’s List traded higher by almost 5% on Monday after Oppenheimer predicted that the company will benefit from a number of factors. The firm noted that a housing recovery, improving margins, and a low valuation relative to its peers will bode well for the company in 2013. Compared to its peers, Oppenheimer is correct, Angie’s List is cheap. However, this note comes just days ahead of the company’s Q4 report; and the stock has already seen a large move during the last three months. Therefore, I commend the analyst’s bravery but would wait for guidance and earnings before buying.

Alere Inc

SolarCity is fast approaching its post-IPO highs after a positive report from GTM Research. The report predicts huge growth in residential solar leases and for SolarCity to benefit with its free/low-cost panel installations in exchange for electricity purchase commitments. GTM believes the market for residential solar could grow from $1.3 billion to $5.7 billion over the next three years and that SolarCity will successfully navigate the shift from commercial to residential. SolarCity is a company that is growing fast with $124 million in revenue, no profit, and a market cap of $1.15 billion. Therefore, it is expensive, but if growth occurs at the rate in GTM’s research notes, then SolarCity could in fact grow rapidly.

Downgrades

After Alere’s near 30% return over the last three months, Wedbush believes that it may be running out of steam. The company has had a history of recent disappointments following earnings, and this downgrade combined with the company set to report earnings on Thursday is most likely fueling the stock’s 5.5% loss. Personally, I agree with the analyst. The stock has run higher, and now with earnings on deck it might be a good time to at least take some profits off the table.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!